Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/- Mice Is Superior to Everolimus Alone (Q38721130)
Jump to navigation
Jump to search
scientific article published on 13 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/- Mice Is Superior to Everolimus Alone |
scientific article published on 13 January 2017 |
Statements
1 reference
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/- Mice Is Superior to Everolimus Alone (English)
1 reference
Jian Yang
1 reference
Paulina A Samsel
1 reference
Kalin Narov
1 reference
Ashley Jones
1 reference
Daniel Gallacher
1 reference
John Gallacher
1 reference
Julian R Sampson
1 reference
Ming Hong Shen
1 reference
13 January 2017
1 reference
1 reference
19
1 reference
112-120
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference